Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has updated the market with a notification of an on-market buy-back, where a total of 64,990 ordinary shares had been repurchased before the previous day, and an additional 1,600 shares were bought back on the previous day. The announcement, dated September 27, 2024, is part of the company’s ongoing strategy to manage its share capital.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
